Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials.
Calvin G BrouwerJoeri A J DoumaEvelien J M KuipSonja ZweegmanNiels W C J van de DonkMaria T E HopmanMyra E van LindeHenk M W VerheulLaurien M BuffartPublished in: Journal of the National Comprehensive Cancer Network : JNCCN (2024)
Repeated smartphone measurements of physical activity are feasible in patients participating in EPCTs. Additionally, physical activity decline is significantly associated with trial discontinuation, PFS, and OS. Hence, we envision that objective smartphone measurements of physical activity will contribute to optimal treatment development for patients with cancer.